Jeffrey Miechels, Niels J M Claessens, Mark V Koning
{"title":"High-Flow Nasal Cannula Reduces Ventilatory Requirements During Endobronchial Ultrasound.","authors":"Jeffrey Miechels, Niels J M Claessens, Mark V Koning","doi":"10.1177/19433654251412342","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>High-flow nasal cannula (HFNC) reduces dead-space ventilation, but this effect is diminished by open-mouth breathing and partial airway obstruction. Consequently, it is uncertain whether HFNC provides respiratory support during endobronchial ultrasound (EBUS) procedures.</p><p><strong>Methods: </strong>A single-center randomized controlled crossover study was conducted at the Rijnstate Hospital, Arnhem, the Netherlands, from November 2022 to August 2024.Patients with severe COPD (Gold III/IV) were evaluated to determine if HFNC reduces dead space ventilation during an EBUS procedure. Exclusion criteria were known neurodegenerative conditions, allergies to propofol or esketamine, pregnancy, upper-airway obstructions, or severe pulmonary hypertension.Subjects received two sequences of HFNC flow (30 and 70 L/min or vice versa) during EBUS.The primary outcome was CO<sub>2</sub> washout, determined by a 60-s capnography trace with and without HFNC flow to measure the difference in inspiratory, end-tidal CO<sub>2</sub>, and β-angle.</p><p><strong>Results: </strong>Twenty subjects with severe COPD (Gold III/IV) were included (Group A <i>n</i> = 10; Group B <i>n</i> = 10), of which one could not complete the bronchial measurements because of an obstructing carcinoma. CO<sub>2</sub> washout at carina was observed at 70 L/min of HFNC flow, demonstrated by a reduced inspiratory CO<sub>2</sub> of mean 6.0 mm Hg (95% CI: 4.5-8.3, <i>P</i> < .001) and end-tidal CO<sub>2</sub> of 5.3 mm Hg (95% CI: 2.3-7.5, <i>P</i> = .002), but not at 30 L/min of HFNC flow (mean inspiratory CO<sub>2</sub> difference of 1.5 mm Hg (95% CI: -2.3 to 6.0, <i>P</i> = .69) and mean end-tidal CO<sub>2</sub> difference of 0.8 mm Hg (95% CI: -2.3 to 3.0, <i>P</i> = .35). A flow of 70 L/min reduced inspiratory CO<sub>2</sub> in the left main bronchus (mean = 5.3 mm Hg; 95% CI: 2.3-8.3, <i>P</i> < .001), but not the end-tidal CO<sub>2</sub> (mean = 3.0 mm Hg; 95% CI: 0.0-6.0, <i>P</i> = .07).</p><p><strong>Conclusions: </strong>An HFNC flow of 70 L/min reduced dead-space ventilation in subjects with severe COPD undergoing EBUS procedures during deep sedation, suggesting respiratory support during this procedure.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":"453-459"},"PeriodicalIF":2.1000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/19433654251412342","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/3 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Background: High-flow nasal cannula (HFNC) reduces dead-space ventilation, but this effect is diminished by open-mouth breathing and partial airway obstruction. Consequently, it is uncertain whether HFNC provides respiratory support during endobronchial ultrasound (EBUS) procedures.
Methods: A single-center randomized controlled crossover study was conducted at the Rijnstate Hospital, Arnhem, the Netherlands, from November 2022 to August 2024.Patients with severe COPD (Gold III/IV) were evaluated to determine if HFNC reduces dead space ventilation during an EBUS procedure. Exclusion criteria were known neurodegenerative conditions, allergies to propofol or esketamine, pregnancy, upper-airway obstructions, or severe pulmonary hypertension.Subjects received two sequences of HFNC flow (30 and 70 L/min or vice versa) during EBUS.The primary outcome was CO2 washout, determined by a 60-s capnography trace with and without HFNC flow to measure the difference in inspiratory, end-tidal CO2, and β-angle.
Results: Twenty subjects with severe COPD (Gold III/IV) were included (Group A n = 10; Group B n = 10), of which one could not complete the bronchial measurements because of an obstructing carcinoma. CO2 washout at carina was observed at 70 L/min of HFNC flow, demonstrated by a reduced inspiratory CO2 of mean 6.0 mm Hg (95% CI: 4.5-8.3, P < .001) and end-tidal CO2 of 5.3 mm Hg (95% CI: 2.3-7.5, P = .002), but not at 30 L/min of HFNC flow (mean inspiratory CO2 difference of 1.5 mm Hg (95% CI: -2.3 to 6.0, P = .69) and mean end-tidal CO2 difference of 0.8 mm Hg (95% CI: -2.3 to 3.0, P = .35). A flow of 70 L/min reduced inspiratory CO2 in the left main bronchus (mean = 5.3 mm Hg; 95% CI: 2.3-8.3, P < .001), but not the end-tidal CO2 (mean = 3.0 mm Hg; 95% CI: 0.0-6.0, P = .07).
Conclusions: An HFNC flow of 70 L/min reduced dead-space ventilation in subjects with severe COPD undergoing EBUS procedures during deep sedation, suggesting respiratory support during this procedure.
期刊介绍:
RESPIRATORY CARE is the official monthly science journal of the American Association for Respiratory Care. It is indexed in PubMed and included in ISI''s Web of Science.